Table 3. .
Study Group |
None, % # |
Mild, % # |
Moderate, % # |
Severe, % # |
Mean, mm ± SD |
Difference in Means, mm ± SD |
P Value for Mean |
|
Day 1 | I (n = 49) | 10% 5 | 29% 14 | 49% 24 | 12% 6 | 63 ± 41 | 3 ± 41 | 1.000 |
IA (n = 53) | 6% 3 | 36% 19 | 53% 28 | 6% 3 | 60 ± 42 | |||
Day 2 | I (n = 36) | 11% 4 | 33% 12 | 42% 15 | 14% 5 | 60 ± 39 | 10 ± 38 | 1.000 |
IA (n = 41) | 10% 4 | 39% 16 | 44% 18 | 7% 3 | 50 ± 37 | |||
Day 3 | I (n = 30) | 10% 3 | 40% 12 | 43% 13 | 7% 2 | 40 ± 34 | 7 ± 34 | 1.000 |
IA (n = 37) | 16% 6 | 40% 15 | 40% 15 | 3% 1 | 47 ± 35 | |||
Day 4 | I (n = 29) | 17% 5 | 48% 14 | 31% 9 | 3% 1 | 26 ± 28 | 16 ± 33 | 1.000 |
IA (n = 35) | 23% 8 | 40% 14 | 31% 11 | 6% 2 | 42 ± 38 |
Patients requiring opioids were excluded on days 2–4.